Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 10Phase 1/2 4Phase 3 1Phase 2/3 1

Status

Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 13Breast Neoplasms 9Neoplasms 6Lung Neoplasms 5Neoplasm Metastasis 4Colorectal Neoplasms 4Breast Neoplasms, Male 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Fallopian Tube Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Inflammatory Breast Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Solid Tumor 1Platinum-Refractory Fallopian Tube Carcinoma 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms, Basal Cell 1Neoplasms by Site 1Neoplasms by Histologic Type 1

Interventions

pembrolizumab 43Nivolumab 24Gemcitabine 23Cyclophosphamide 21Paclitaxel 17Capecitabine 16fludarabine 14Ipilimumab 14aldesleukin 11Docetaxel 11130-nm albumin-bound paclitaxel 11Trastuzumab 10Cetuximab 10Bevacizumab 10Albumin-Bound Paclitaxel 9fludarabine phosphate 8Specimen Handling 8Interleukin-2 8Fluorouracil 8Cisplatin 8Biopsy 8Radiosurgery 7Oxaliplatin 7Irinotecan 7durvalumab 6avelumab 6Temozolomide 6Pemetrexed 6Leucovorin 6Carboplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasm Metastasis × Taxes × Clear all
NCT07049055 2026-02-27

Carolyn-USA

Engeneic Pty Limited

Phase 1/2 Recruiting
144 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Disease Progression

NCT06320405 2025-12-29

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

OHSU Knight Cancer Institute

Phase 1/2 Recruiting
38 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04983407 2023-10-30

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Aravive, Inc.

Phase 1/2 Terminated
34 enrolled

Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT04430933 2021-08-18

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

NextCure, Inc.

Phase 1/2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡